Join
Live feed
·
INSIDERFilingvia Quantisnow
Catalent Inc. logo

Group President, Biologics Mcerlane David sold $119,580 worth of shares (1,994 units at $59.97), decreasing direct ownership by 5% to 36,304 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CTLT· Catalent Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTLT (Catalent Inc.) and more on Quantisnow.